Virtual gene editing startup to lease Cambridge lab after $40M round

The company, Exonics Therapeutics, said the Series A round will allow it to hire scientists to conduct preclinical research into a potential treatment for Duchenne muscular dystrophy.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news